Literature DB >> 25171057

Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

E M Moran1, F L Mastaglia.   

Abstract

The idiopathic inflammatory myopathies are a heterogeneous group of disorders characterised by diffuse muscle weakness and inflammation. A common immunopathogenic mechanism is the cytokine-driven infiltration of immune cells into the muscle tissue. Recent studies have further dissected the inflammatory cell types and associated cytokines involved in the immune-mediated myopathies and other chronic inflammatory and autoimmune disorders. In this review we outline the current knowledge of cytokine expression profiles and cellular sources in the major forms of inflammatory myopathy and detail the known mechanistic functions of these cytokines in the context of inflammatory myositis. Furthermore, we discuss how the application of this knowledge may lead to new therapeutic strategies for the treatment of the inflammatory myopathies, in particular for cases resistant to conventional forms of therapy.
© 2014 British Society for Immunology.

Entities:  

Keywords:  autoimmunity; autoinflammatory disease; cytokines; inflammation; neuroimmunology

Mesh:

Substances:

Year:  2014        PMID: 25171057      PMCID: PMC4238868          DOI: 10.1111/cei.12445

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  109 in total

1.  Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Interleukin-27: a master regulator in inflammation.

Authors:  Ursula Fearon
Journal:  Arthritis Rheum       Date:  2011-08

Review 3.  Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.

Authors:  Valerie Askanas; W King Engel; Anna Nogalska
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

4.  Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells.

Authors:  K Arahata; A G Engel
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

5.  Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.

Authors:  I Lundberg; A K Ulfgren; P Nyberg; U Andersson; L Klareskog
Journal:  Arthritis Rheum       Date:  1997-05

6.  Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.

Authors:  Raghavan Raju; Marinos C Dalakas
Journal:  Brain       Date:  2005-04-27       Impact factor: 13.501

7.  Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis.

Authors:  M Caproni; D Torchia; C Cardinali; W Volpi; E Del Bianco; A D'Agata; P Fabbri
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

Review 8.  Cytokine synergy: an underappreciated contributor to innate anti-viral immunity.

Authors:  Eric Bartee; Grant McFadden
Journal:  Cytokine       Date:  2013-05-18       Impact factor: 3.861

9.  Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.

Authors:  Jana Zschüntzsch; Joachim Voss; Kim Creus; Stephan Sehmisch; Raghavan Raju; Marinos C Dalakas; Jens Schmidt
Journal:  Arthritis Rheum       Date:  2012-12

10.  Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.

Authors:  Sree Rayavarapu; William Coley; Travis B Kinder; Kanneboyina Nagaraju
Journal:  Skelet Muscle       Date:  2013-06-07       Impact factor: 4.912

View more
  33 in total

1.  Refractory polymyositis undergoing remission following antitubercular therapy.

Authors:  Durga Prasanna Misra; Sukesh Edavalath; Abhra Chandra Chowdhury; Vikas Agarwal
Journal:  BMJ Case Rep       Date:  2015-04-22

2.  Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets.

Authors:  F Espinosa-Ortega; D Gómez-Martin; K Santana-De Anda; J Romo-Tena; P Villaseñor-Ovies; J Alcocer-Varela
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

3.  Quinacrine Suppresses Tumor Necrosis Factor-α and IFN-α in Dermatomyositis and Cutaneous Lupus Erythematosus.

Authors:  Paul Alves; Muhammad M Bashir; Maria Wysocka; Majid Zeidi; Rui Feng; Victoria P Werth
Journal:  J Investig Dermatol Symp Proc       Date:  2017-10

Review 4.  The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.

Authors:  Angela Ceribelli; Maria De Santis; Natasa Isailovic; M Eric Gershwin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 5.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

6.  Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.

Authors:  Lijuan Wang; Yanchun Quan; Yongfang Yue; Xueyuan Heng; Fengyuan Che
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

7.  Immune-mediated necrotising myopathy: a rare cause of hyperCKaemia.

Authors:  Emily Liang; Mandana Rastegar
Journal:  BMJ Case Rep       Date:  2018-04-24

Review 8.  Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Authors:  Merrilee Needham; Frank L Mastaglia
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

9.  Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD).

Authors:  Abbe N Vallejo; Henry J Mroczkowski; Joshua J Michel; Michael Woolford; Harry C Blair; Patricia Griffin; Elizabeth McCracken; Stephanie J Mihalik; Miguel Reyes-Mugica; Jerry Vockley
Journal:  Clin Transl Immunology       Date:  2021-06-27

10.  The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up.

Authors:  Maja Špiritović; Barbora Heřmánková; Sabína Oreská; Hana Štorkánová; Olga Růžičková; Lucia Vernerová; Martin Klein; Kateřina Kubínová; Hana Šmucrová; Adéla Rathouská; Petr Česák; Martin Komarc; Václav Bunc; Karel Pavelka; Ladislav Šenolt; Heřman Mann; Jiří Vencovský; Michal Tomčík
Journal:  Arthritis Res Ther       Date:  2021-06-21       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.